[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.] #  @TaxiBiotech TaxiBiotech TaxiBiotech posts on X about $crnx, $regn, $nvo, abbv the most. They currently have XXX followers and XXX posts still getting attention that total XXX engagements in the last XX hours. ### Engagements: XXX [#](/creator/twitter::1340292496937644033/interactions)  - X Week XXXXX -XX% - X Month XXXXXX +64% - X Months XXXXXX +306% - X Year XXXXXX +12,396% ### Mentions: XX [#](/creator/twitter::1340292496937644033/posts_active)  - X Week XX +50% - X Month XX +74% - X Months XXX +106% - X Year XXX +3,367% ### Followers: XXX [#](/creator/twitter::1340292496937644033/followers)  - X Week XXX +1.10% - X Month XXX +98% - X Months XXX +363% ### CreatorRank: XXXXXXXXX [#](/creator/twitter::1340292496937644033/influencer_rank)  ### Social Influence [#](/creator/twitter::1340292496937644033/influence) --- **Social category influence** [stocks](/list/stocks) [cryptocurrencies](/list/cryptocurrencies) [finance](/list/finance) [exchanges](/list/exchanges) [countries](/list/countries) **Social topic influence** [$crnx](/topic/$crnx), [$regn](/topic/$regn), [$nvo](/topic/$nvo), [abbv](/topic/abbv), [pfe](/topic/pfe), [$gpcr](/topic/$gpcr), [$lly](/topic/$lly), [drugs](/topic/drugs), [weight loss](/topic/weight-loss), [$vik](/topic/$vik) **Top assets mentioned** [Crinetics Pharmaceuticals, Inc. (CRNX)](/topic/$crnx) [Regeneron Pharmaceuticals Inc (REGN)](/topic/$regn) [Novo-Nordisk (NVO)](/topic/$nvo) [Eli Lilly and Company (LLY)](/topic/$lly) [Viking Holdings Ltd (VIK)](/topic/$vik) [Viking Therapeutics, Inc (VKTX)](/topic/$vktx) [Amgen, Inc. (AMGN)](/topic/$amgn) [Pfizer, Inc. (PFE)](/topic/$pfe) [AbbVie Inc (ABBV)](/topic/$abbv) [Metsera, Inc. Common Stock (MTSR)](/topic/$mtsr) [SuperRare (RARE)](/topic/$rare) [Insmed, Inc. (INSM)](/topic/$insm) [Jazz Pharmaceuticals, Inc. (JAZZ)](/topic/$jazz) [PTC Therapeutics, Inc. (PTCT)](/topic/$ptct) [Hundred Million (100M)](/topic/$100m) [Bitcoin (BTC)](/topic/bitcoin) [Biogen Inc (BIIB)](/topic/$biib) [Agios Pharmaceuticals, Inc. (AGIO)](/topic/$agio) [Ionis Pharmaceuticals, Inc. Common Stock (IONS)](/topic/$ions) [Royalty Pharma plc Class A Ordinary Shares (RPRX)](/topic/$rprx) ### Top Social Posts [#](/creator/twitter::1340292496937644033/posts) --- Top posts by engagements in the last XX hours "#PDUFA #FDA approval days for August: XX $LENZ LNZ100 presbyopia XX $PHRRF.OB KETAMINE (RESUB). Anesthesia pain. XX $INSM BRENSOCATIB. non-CF bronchiectasis XX $TNXP TNX-102 SL. Fibromyalgia XX $JAZZ / $CMRX DORDAPRIVONE. H3 K27M-Mutant diffuse glioma XX $RARE / $ABEO UX111 AAV. Sanfilippo XX $PTCT VATIQUINONE. children and adults Friedreich's ataxia XX $REGN / BAYER EYLEA HD. Macular edema XX $IONS DONIDALORSEN. Angioedema +12yo XX $PGEN PRGN-2012. Respiratory papillomatosis XX $TLX TLX250-CDx. Cancer PET imaging XX $OTLK ONS-5010 (RESUB). Macular degeneration XX $TVTX $LGND FILSPARI."  [@TaxiBiotech](/creator/x/TaxiBiotech) on [X](/post/tweet/1947207359270363208) 2025-07-21 08:09:46 UTC XXX followers, XXX engagements "ππΈ Weight loss drugs: Caution How do they work Risks benefits worth it Open debate. π +Obesity business: Lilly $LLY / Novo $NVO lead the market. Are rivals too late Viking $VKTX $AMGN $PFE $REGN $ABBV $CRNX $GPCR $MTSR π@TaxiBiotech"  [@TaxiBiotech](/creator/x/TaxiBiotech) on [X](/post/tweet/1944635944893858203) 2025-07-14 05:51:53 UTC XXX followers, 2244 engagements "I-Mab $IMAB 𧬠Ph1b dose escalation: givastomig (Claudin18.2 4-1BB bispecific) + nivolumab + mFOLFOX6 in 1stLine gastric cancer β ORR: XX% (13/18); XX% (10/12) at expansion dose 𧬠Responses seen even with low PD-L1/CLDN18.2 broader reach π©Ί Mostly Gr12 TRAEs. X pt (5.6%) Gr3 transaminase π ESMO GI 2025 (Tue 8th) #Biotech #IO #Bispecifics #ESMOGI"  [@TaxiBiotech](/creator/x/TaxiBiotech) on [X](/post/tweet/1940456762756288748) 2025-07-02 17:05:18 UTC XXX followers, XXX engagements "π¨ Another NASDAQ BIO chasing BTC BITCOIN Desperate moves are spreading across this sector. What do you think Profusa ( $PFSA ) secures a $100M equity line with Ascent to launch a Bitcoin treasury strategy πͺ β Theyll issue shares maintain a $5M cash buffer and deploy the rest to buy Bitcoin; which could later be used to repay debt if needed"  [@TaxiBiotech](/creator/x/TaxiBiotech) on [X](/post/tweet/1947346305174671645) 2025-07-21 17:21:53 UTC XXX followers, XXX engagements "π¨π July 19: $LXRX Lexicon to present a poster at ASPN 2025 on pilavapadin (LX9211) for diabetic neuropathic pain π§ β Last time they presented LX9211 data the stock dropped over XX% due to lack of statistical significance. π It later rebounded after the $NVO deal π Poster title: Listening to Patients with Diabetic Peripheral Neuropathic Pain: Insights from a Patient Survey to Inform Advanced Clinical Development of Pilavapadin π With that title. I THINK no new clinical data is coming. Just a patient survey to guide future development More qualitative than clinical Stock down X% today"  [@TaxiBiotech](/creator/x/TaxiBiotech) on [X](/post/tweet/1946256686223601960) 2025-07-18 17:12:08 UTC XXX followers, XXX engagements "ππΈ Weight loss drugs: Caution How do they work Risks benefits worth it Open debate. π +Obesity business: Lilly $LLY / Novo $NVO lead the market. Are rivals too late Viking $VKTX $AMGN $PFE $REGN $ABBV $CRNX $GPCR $MTSR π Watch on @TaxiBiotech"  [@TaxiBiotech](/creator/x/TaxiBiotech) on [X](/post/tweet/1944105082682806689) 2025-07-12 18:42:26 UTC XXX followers, XXX engagements "$MESO Mesoblasts Ryoncil (remestemcel-L) commercial launch recap: First & only FDA-approved MSC therapy for pediatric steroid-refractory acute graft-versus-host disease $13.2M in Q2 gross sales (Mar 28Jun 30) $1.6M in royalties from TEMCELL sales in Japan Now covered by Medicare/Medicaid 7-year orphan drug exclusivity + 12-year BLA protection XX US transplant centers onboarded targeting XX π₯ #Biotech #CellTherapy"  [@TaxiBiotech](/creator/x/TaxiBiotech) on [X](/post/tweet/1946079510169829826) 2025-07-18 05:28:06 UTC XXX followers, XXX engagements "π§ͺ Yesterday was Crinetics $CRNX #RDInvestorDay. They presented preclinical programs and candidates either in phase 1/2 or about to submit new INDs. Lets walk through what they shared. π Thread:"  [@TaxiBiotech](/creator/x/TaxiBiotech) on [X](/post/tweet/1938536489354179032) 2025-06-27 09:54:49 UTC XXX followers, XXX engagements "#PDUFA #FDA approval days for September: XX $AXGN AVANCE NERVE GRAFT. Surgical repair. XX $AGIO PYRUKYND. Anemia for PK deficiency in a/b-thalassemia. XX $BCRX ORLADEYO. Hereditary angioedema +2yo. XX $SRKK APITEGROMAB. Spinal muscular atrophy. XX $IONS $BIIB SPINRAZA. Higher dose for spinal muscular atrophy. XX $CRNX PALTUSOTINE. Acromegaly. XX $RPRX AFICAMTEN. Obstructive hypertrophic cardiomyopathy. XX $SNY TOLEBRUTINIB. Multiple sclerosis. XX $FBIO CUTX-101. Menkes disease. Late Sept $OMER NARSOPLIMAB. Transplant-associated thrombotic microangiopathy. source:"  [@TaxiBiotech](/creator/x/TaxiBiotech) on [X](/post/tweet/1947239254444171571) 2025-07-21 10:16:30 UTC XXX followers, XXX engagements "ππΈ Weight loss drugs: Caution How do they work Risks benefits worth it Open debate π + Obesity STOCKS: Lilly $LLY and Novo $NVO lead the market. Are rivals too late Viking $VKTX $AMGN $PFE $REGN $ABBV $CRNX $GPCR $MTSR π Watch on @TaxiBiotech"  [@TaxiBiotech](/creator/x/TaxiBiotech) on [X](/post/tweet/1944104848695136610) 2025-07-12 18:41:30 UTC XXX followers, XXX engagements "ProMis Neurosciences $PMN π¨ FDA grants Fast Track to PMN310 for #Alzheimerπ§ PMN310 Targets only toxic soluble amyloid-beta sparing normal A and plaques. Fewer side effects more precision. #biotech #Neuroscience"  [@TaxiBiotech](/creator/x/TaxiBiotech) on [X](/post/tweet/1947343360856911992) 2025-07-21 17:10:11 UTC XXX followers, XXX engagements
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
TaxiBiotech posts on X about $crnx, $regn, $nvo, abbv the most. They currently have XXX followers and XXX posts still getting attention that total XXX engagements in the last XX hours.
Social category influence stocks cryptocurrencies finance exchanges countries
Social topic influence $crnx, $regn, $nvo, abbv, pfe, $gpcr, $lly, drugs, weight loss, $vik
Top assets mentioned Crinetics Pharmaceuticals, Inc. (CRNX) Regeneron Pharmaceuticals Inc (REGN) Novo-Nordisk (NVO) Eli Lilly and Company (LLY) Viking Holdings Ltd (VIK) Viking Therapeutics, Inc (VKTX) Amgen, Inc. (AMGN) Pfizer, Inc. (PFE) AbbVie Inc (ABBV) Metsera, Inc. Common Stock (MTSR) SuperRare (RARE) Insmed, Inc. (INSM) Jazz Pharmaceuticals, Inc. (JAZZ) PTC Therapeutics, Inc. (PTCT) Hundred Million (100M) Bitcoin (BTC) Biogen Inc (BIIB) Agios Pharmaceuticals, Inc. (AGIO) Ionis Pharmaceuticals, Inc. Common Stock (IONS) Royalty Pharma plc Class A Ordinary Shares (RPRX)
Top posts by engagements in the last XX hours
"#PDUFA #FDA approval days for August: XX $LENZ LNZ100 presbyopia XX $PHRRF.OB KETAMINE (RESUB). Anesthesia pain. XX $INSM BRENSOCATIB. non-CF bronchiectasis XX $TNXP TNX-102 SL. Fibromyalgia XX $JAZZ / $CMRX DORDAPRIVONE. H3 K27M-Mutant diffuse glioma XX $RARE / $ABEO UX111 AAV. Sanfilippo XX $PTCT VATIQUINONE. children and adults Friedreich's ataxia XX $REGN / BAYER EYLEA HD. Macular edema XX $IONS DONIDALORSEN. Angioedema +12yo XX $PGEN PRGN-2012. Respiratory papillomatosis XX $TLX TLX250-CDx. Cancer PET imaging XX $OTLK ONS-5010 (RESUB). Macular degeneration XX $TVTX $LGND FILSPARI." @TaxiBiotech on X 2025-07-21 08:09:46 UTC XXX followers, XXX engagements
"ππΈ Weight loss drugs: Caution How do they work Risks benefits worth it Open debate. π +Obesity business: Lilly $LLY / Novo $NVO lead the market. Are rivals too late Viking $VKTX $AMGN $PFE $REGN $ABBV $CRNX $GPCR $MTSR π@TaxiBiotech" @TaxiBiotech on X 2025-07-14 05:51:53 UTC XXX followers, 2244 engagements
"I-Mab $IMAB 𧬠Ph1b dose escalation: givastomig (Claudin18.2 4-1BB bispecific) + nivolumab + mFOLFOX6 in 1stLine gastric cancer β
ORR: XX% (13/18); XX% (10/12) at expansion dose 𧬠Responses seen even with low PD-L1/CLDN18.2 broader reach π©Ί Mostly Gr12 TRAEs. X pt (5.6%) Gr3 transaminase π ESMO GI 2025 (Tue 8th) #Biotech #IO #Bispecifics #ESMOGI" @TaxiBiotech on X 2025-07-02 17:05:18 UTC XXX followers, XXX engagements
"π¨ Another NASDAQ BIO chasing BTC BITCOIN Desperate moves are spreading across this sector. What do you think Profusa ( $PFSA ) secures a $100M equity line with Ascent to launch a Bitcoin treasury strategy πͺ β
Theyll issue shares maintain a $5M cash buffer and deploy the rest to buy Bitcoin; which could later be used to repay debt if needed" @TaxiBiotech on X 2025-07-21 17:21:53 UTC XXX followers, XXX engagements
"π¨π
July 19: $LXRX Lexicon to present a poster at ASPN 2025 on pilavapadin (LX9211) for diabetic neuropathic pain π§ β Last time they presented LX9211 data the stock dropped over XX% due to lack of statistical significance. π It later rebounded after the $NVO deal π Poster title: Listening to Patients with Diabetic Peripheral Neuropathic Pain: Insights from a Patient Survey to Inform Advanced Clinical Development of Pilavapadin π With that title. I THINK no new clinical data is coming. Just a patient survey to guide future development More qualitative than clinical Stock down X% today" @TaxiBiotech on X 2025-07-18 17:12:08 UTC XXX followers, XXX engagements
"ππΈ Weight loss drugs: Caution How do they work Risks benefits worth it Open debate. π +Obesity business: Lilly $LLY / Novo $NVO lead the market. Are rivals too late Viking $VKTX $AMGN $PFE $REGN $ABBV $CRNX $GPCR $MTSR π Watch on @TaxiBiotech" @TaxiBiotech on X 2025-07-12 18:42:26 UTC XXX followers, XXX engagements
"$MESO Mesoblasts Ryoncil (remestemcel-L) commercial launch recap: First & only FDA-approved MSC therapy for pediatric steroid-refractory acute graft-versus-host disease $13.2M in Q2 gross sales (Mar 28Jun 30) $1.6M in royalties from TEMCELL sales in Japan Now covered by Medicare/Medicaid 7-year orphan drug exclusivity + 12-year BLA protection XX US transplant centers onboarded targeting XX π₯ #Biotech #CellTherapy" @TaxiBiotech on X 2025-07-18 05:28:06 UTC XXX followers, XXX engagements
"π§ͺ Yesterday was Crinetics $CRNX #RDInvestorDay. They presented preclinical programs and candidates either in phase 1/2 or about to submit new INDs. Lets walk through what they shared. π Thread:" @TaxiBiotech on X 2025-06-27 09:54:49 UTC XXX followers, XXX engagements
"#PDUFA #FDA approval days for September: XX $AXGN AVANCE NERVE GRAFT. Surgical repair. XX $AGIO PYRUKYND. Anemia for PK deficiency in a/b-thalassemia. XX $BCRX ORLADEYO. Hereditary angioedema +2yo. XX $SRKK APITEGROMAB. Spinal muscular atrophy. XX $IONS $BIIB SPINRAZA. Higher dose for spinal muscular atrophy. XX $CRNX PALTUSOTINE. Acromegaly. XX $RPRX AFICAMTEN. Obstructive hypertrophic cardiomyopathy. XX $SNY TOLEBRUTINIB. Multiple sclerosis. XX $FBIO CUTX-101. Menkes disease. Late Sept $OMER NARSOPLIMAB. Transplant-associated thrombotic microangiopathy. source:" @TaxiBiotech on X 2025-07-21 10:16:30 UTC XXX followers, XXX engagements
"ππΈ Weight loss drugs: Caution How do they work Risks benefits worth it Open debate π + Obesity STOCKS: Lilly $LLY and Novo $NVO lead the market. Are rivals too late Viking $VKTX $AMGN $PFE $REGN $ABBV $CRNX $GPCR $MTSR π Watch on @TaxiBiotech" @TaxiBiotech on X 2025-07-12 18:41:30 UTC XXX followers, XXX engagements
"ProMis Neurosciences $PMN π¨ FDA grants Fast Track to PMN310 for #Alzheimerπ§ PMN310 Targets only toxic soluble amyloid-beta sparing normal A and plaques. Fewer side effects more precision. #biotech #Neuroscience" @TaxiBiotech on X 2025-07-21 17:10:11 UTC XXX followers, XXX engagements
/creator/x::TaxiBiotech